BAKER BROS. ADVISORS LP
Q4 2025 13F Holdings
- Locationnew york, NY
- Num holdings
86
- Value ($000)
$17,078,624
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001263508
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Incyte Corporation | COM | 45337C102 | $3.04B | 18 % | 30,743,991 | ||
BeOne Medicines Ltd. | SPONSORED ADS | 07725L102 | $2.67B | 16 % | 8,799,053 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | $1.25B | 7 % | 2,141,701 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | $1.15B | 7 % | 6,592,746 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | $1.15B | 7 % | 42,896,690 | ||
Celcuity Inc. | COM | 15102K100 | $789.52M | 5 % | 7,915,792 | ||
Revolution Medicines, Inc. | COM | 76155X100 | $753.12M | 4 % | 9,455,357 | ||
Kymera Therapeutics, Inc. | COM | 501575104 | $673.62M | 4 % | 8,657,242 | ||
Summit Therapeutics Inc. | COM | 86627T108 | $636.48M | 4 % | 36,391,063 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | $599.9M | 4 % | 5,604,483 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100